EleftheriosPMamounasMD
General Surgery • Orlando, FLBreast, Surgical Oncology (Other than Breast)
Professor of Surgery, Northeast Ohio Medical University
Dr. Mamounas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Orlando Health Cancer Institute
1414 Kuhl Ave
Orlando, FL 32806- Is this information wrong?
Education & Training
UPMC Medical Education (Pittsburgh)Residency, Surgery, 1984 - 1989
University of AthensClass of 1983
Certifications & Licensure
FL State Medical License 2012 - 2025
OH State Medical License 1997 - 2014
PA State Medical License 1985 - 1998- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Fluorescence Imaging of Carcinoma During Breast Conserving Surgery Start of enrollment: 2021 Apr 27
Roles: Principal Investigator
Publications & Presentations
PubMed
- Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K Chia, Adam M Brufsky, Janice ...> ;Clinical Cancer Research. 2024 Feb 20
- Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).Geyer, C., Blum, J., Yothers, G., Asmar, L., Flynn, P., Robert, N., Hopkins, J., O'Shaughnessy, J., Rastogi, P., Puhalla, S., Hilton, C., Dang, C., Gómez, H., Vukelja,...> ;Journal of Clinical Oncology. 2024 Feb 9
- 1 citationsImpact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.Georg Pfeiler, Dominik Hlauschek, Erica L Mayer, Christine Deutschmann, Stephanie Kacerovsky-Strobl, Miguel Martin, Jane Lowe Meisel, Nicholas Zdenkowski, Sibylle Loib...> ;Journal of Clinical Oncology. 2023 Nov 20
- Join now to see all
Journal Articles
- 21-Gene Assay as Predictor of Chemotherapy Benefit in HER2-Negative Breast CancerEleftherios P Mamounas, Frederick L Baehner, Norman Wolmark, D Lawrence Wickerham, Nature
- Clinical Relevance of the 21-Gene Recurrence Score® Assay in Treatment Decisions for Patients with Node-Positive Breast Cancer in the Genomic EraEleftherios Mamounas, MD, Nature
Lectures
- NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ...2019 ASCO Annual Meeting - 6/1/2019
- NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy plus Endocrine Therapy: Results from NSABP B-28/NRG OncologyNovember 11th, 2019
Do Trials Results Conflict for Extended AI in Breast Cancer?December 8th, 2016
Conversations with Oncology Investigators Bridging the Gap Between Research and Patient CareDecember 26th, 2007- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
Orlando Health Orlando Regional Medical CenterOrlando, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
